Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gooley

Showing results (521-530 of 956) with videos related to

Pageof 96
Sort By:
Nuclear Medicine Communications|September 8, 2012
131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testesNaoya Hattori, Ajay K Gopal, Andrew T Shields, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and olderHerschel Wallen, Theodore A Gooley, H Joachim Deeg, et al.
The Journal of Biological Chemistry|August 9, 2013
The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activationRoy C K Kong, Emma J Petrie, Biswaranjan Mohanty, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2010
Re: An approach to predicting HSCT outcome using HLA-mismatch information mapped on protein structure dataCarolyn K Hurley, Machteld Oudshoorn, Michelle Setterholm, et al.
Cardiovascular Diagnosis and Therapy|July 8, 2022
Diagnostic performance of quantitative flow ratio, non-hyperaemic pressure indices and fractional flow reserve for the assessment of coronary lesions in severe aortic stenosisCameron Dowling, Michael Michail, Jun Michael Zhang, et al.
Pharmacology & Therapeutics|February 20, 2018
The relaxin receptor as a therapeutic target - perspectives from evolution and drug targetingRoss A D Bathgate, Martina Kocan, Daniel J Scott, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2017
Bioprosthetic aortic valve leaflet thrombosis detected by multidetector computed tomography is associated with adverse cerebrovascular events: a meta-analysis of observational studiesHashrul N Rashid, Robert P Gooley, Nitesh Nerlekar, et al.
The FEBS Journal|May 24, 2018
Polymorphism in disease-related apolipoprotein C-II amyloid fibrils: a structural model for rod-like fibrilsCourtney O Zlatic, Yu Mao, Nevena Todorova, et al.
Blood Advances|February 19, 2025
Long-term outcomes and quality of life with treosulfan-based conditioning in hematological malignanciesRohtesh S Mehta, Stephanie J Lee, Ted Gooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2018
Patient HLA Germline Variation and Transplant SurvivorshipEffie W Petersdorf, Philip Stevenson, Mari Malkki, et al.
Pageof 96

Showing results (521-530 of 956) with videos related to

Sort By:
Pageof 96
Nuclear Medicine Communications|September 8, 2012
131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testesNaoya Hattori, Ajay K Gopal, Andrew T Shields, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and olderHerschel Wallen, Theodore A Gooley, H Joachim Deeg, et al.
The Journal of Biological Chemistry|August 9, 2013
The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activationRoy C K Kong, Emma J Petrie, Biswaranjan Mohanty, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2010
Re: An approach to predicting HSCT outcome using HLA-mismatch information mapped on protein structure dataCarolyn K Hurley, Machteld Oudshoorn, Michelle Setterholm, et al.
Cardiovascular Diagnosis and Therapy|July 8, 2022
Diagnostic performance of quantitative flow ratio, non-hyperaemic pressure indices and fractional flow reserve for the assessment of coronary lesions in severe aortic stenosisCameron Dowling, Michael Michail, Jun Michael Zhang, et al.
Pharmacology & Therapeutics|February 20, 2018
The relaxin receptor as a therapeutic target - perspectives from evolution and drug targetingRoss A D Bathgate, Martina Kocan, Daniel J Scott, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2017
Bioprosthetic aortic valve leaflet thrombosis detected by multidetector computed tomography is associated with adverse cerebrovascular events: a meta-analysis of observational studiesHashrul N Rashid, Robert P Gooley, Nitesh Nerlekar, et al.
The FEBS Journal|May 24, 2018
Polymorphism in disease-related apolipoprotein C-II amyloid fibrils: a structural model for rod-like fibrilsCourtney O Zlatic, Yu Mao, Nevena Todorova, et al.
Blood Advances|February 19, 2025
Long-term outcomes and quality of life with treosulfan-based conditioning in hematological malignanciesRohtesh S Mehta, Stephanie J Lee, Ted Gooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2018
Patient HLA Germline Variation and Transplant SurvivorshipEffie W Petersdorf, Philip Stevenson, Mari Malkki, et al.
Pageof 96